Literature DB >> 29297488

Mucinous and secondary tumors of the prostate.

Adeboye O Osunkoya1,2,3,4.   

Abstract

Primary mucinous tumors and secondary tumors involving the prostate gland are relatively uncommon, however they have important diagnostic, therapeutic, and prognostic implications. The primary mucinous tumors of the prostate include mucinous (colloid) adenocarcinoma of the prostate, prostatic adenocarcinoma with mucinous features, and mucinous adenocarcinoma of the prostatic urethra (mucin-producing urothelial-type adenocarcinoma of the prostate). Mucinous adenocarcinoma of the prostate is defined as a primary prostatic acinar tumor characterized by the presence of at least 25% of the tumor composed of glands with extraluminal mucin. This diagnosis can only be made in radical prostatectomy specimens. Recent studies have shown that these tumors have a similar or in some cases better prognosis than conventional prostatic adenocarcinoma treated by radical prostatectomy. The preferred terminology for tumors that are composed of <25% extraluminal mucinous component in radical prostatectomy specimens is 'prostatic adenocarcinoma with mucinous features.' All cases of prostatic adenocarcinoma with extraluminal mucinous components in prostate needle core biopsies or transurethral resection of the prostate specimens are also referred to as 'prostatic adenocarcinoma with mucinous features.' Mucinous adenocarcinoma of the prostatic urethra (mucin-producing urothelial-type adenocarcinoma of the prostate) as the name implies, does not arise from prostatic acini or ducts, and is a distinct entity that arises from the prostatic urethra usually from urethritis glandularis or glandular metaplasia with malignant transformation, and is analogous to adenocarcinoma with mucinous differentiation arising from the urinary bladder. This tumor is aggressive and has a relatively poor prognosis. The most common secondary tumors that arise from adjacent organs and spread (direct extension or metastasis) to the prostate gland, include urothelial carcinoma of the bladder and colorectal adenocarcinoma. Other secondary tumors that may involve the prostate include metastatic epithelial tumors from several other sites, malignant melanoma and soft tissue tumors.

Entities:  

Mesh:

Year:  2018        PMID: 29297488     DOI: 10.1038/modpathol.2017.132

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  3 in total

1.  Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma.

Authors:  Kunihisa Nezu; Teppei Okubo; Manabu Shiraiwa; Yoshihiro Nozawa; Atsushi Kyan
Journal:  IJU Case Rep       Date:  2020-08-02

2.  Management about intravesical histological transformation of prostatic mucinous carcinoma after radical prostatectomy: A case report.

Authors:  Sheng-Jiang Bai; Li Ma; Min Luo; Hang Xu; Lu Yang
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

3.  Mucin-producing urothelial-type adenocarcinoma of the prostate diagnosed after robot-assisted radical prostatectomy.

Authors:  Kosuke Shimizu; Ryo Inoue; Shinobu Tomochika; Naohito Isoyama; Yoshiaki Yamamoto; Hiroaki Matsumoto; Koji Shiraishi; Shigefumi Yoshino; Toyonori Tsuzuki; Hideyasu Matsuyama
Journal:  IJU Case Rep       Date:  2021-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.